Summary
GlobalData's new report, "United States Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020", provides key market data on the United States Cardiovascular Monitoring and Diagnostic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Monitoring and Diagnostic Devices market wherever available.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Eslicarbazepine acetate is a drug that was developed by Bial-Portela & Ca., and is currently in Phase III of clinical development for PDN and PHN. It has already been approved for marketing in Europe and the US for the adjunctive treatment of adults with partial epileptic seizures. It was launched in the EU by Bial in conjunction with Eisai in 2009, and received FDA approval in the US in November 2013, where it is being developed and commercialized by Sunovion Pharmaceuticals under the brand name Aptiom.
Reasons to buy
Table of Contents
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Cardiovascular Monitoring and Diagnostic Devices Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10
3 Cardiovascular Monitoring and Diagnostic Devices Market, United States 12
3.1 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2005-2012 12
3.2 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2012-2020 14
3.3 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2005-2012 16
3.4 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2012-2020 18
3.5 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), 2005-2020 20
3.6 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), 2011-2012 22
3.7 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share by Revenue ($m), 2011-2012 23
4 Overview of Key Companies in United States, Cardiovascular Monitoring and Diagnostic Devices Market 25
4.1 GE Healthcare 25
4.1.1 Company Overview 25
4.2 Philips Healthcare 25
4.2.1 Company Overview 25
4.3 CareFusion Corporation 25
4.3.1 Company Overview 25
4.4 Welch Allyn Inc. 26
4.4.1 Company Overview 26
4.5 OSI Systems, Inc. 26
4.5.1 Company Overview 26
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: sales@hexareports.com
Website: http://www.hexareports.com/
GlobalData's new report, "United States Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020", provides key market data on the United States Cardiovascular Monitoring and Diagnostic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Monitoring and Diagnostic Devices market wherever available.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
Browse Detail Report with TOC @ http://www.hexareports.com/report/united-states-cardiovascular-monitoring-and-diagnostic-devices-market-outlook-to-2020/details
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Eslicarbazepine acetate is a drug that was developed by Bial-Portela & Ca., and is currently in Phase III of clinical development for PDN and PHN. It has already been approved for marketing in Europe and the US for the adjunctive treatment of adults with partial epileptic seizures. It was launched in the EU by Bial in conjunction with Eisai in 2009, and received FDA approval in the US in November 2013, where it is being developed and commercialized by Sunovion Pharmaceuticals under the brand name Aptiom.
Request a Sample copy of This Report @ http://www.hexareports.com/sample/41969Scope
- Market size for Cardiovascular Monitoring and Diagnostic Devices categories Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.
- Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for the market category.
- Global corporate-level profiles of key companies operating within the United States Cardiovascular Monitoring and Diagnostic Devices market.
- Key players covered include GE Healthcare, Philips Healthcare, Welch Allyn Inc., OSI Systems, Inc., CareFusion Corporation, Cardiac Science Corporation, Schiller AG and Card Guard Scientific Survival, Ltd.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution Identify, understand and capitalize.
Table of Contents
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Cardiovascular Monitoring and Diagnostic Devices Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10
3 Cardiovascular Monitoring and Diagnostic Devices Market, United States 12
3.1 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2005-2012 12
3.2 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2012-2020 14
3.3 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2005-2012 16
3.4 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2012-2020 18
3.5 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), 2005-2020 20
3.6 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), 2011-2012 22
3.7 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share by Revenue ($m), 2011-2012 23
4 Overview of Key Companies in United States, Cardiovascular Monitoring and Diagnostic Devices Market 25
4.1 GE Healthcare 25
4.1.1 Company Overview 25
4.2 Philips Healthcare 25
4.2.1 Company Overview 25
4.3 CareFusion Corporation 25
4.3.1 Company Overview 25
4.4 Welch Allyn Inc. 26
4.4.1 Company Overview 26
4.5 OSI Systems, Inc. 26
4.5.1 Company Overview 26
Browse Full Report @ http://www.hexareports.com/report/united-states-cardiovascular-monitoring-and-diagnostic-devices-market-outlook-to-2020/detailsAbout Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: sales@hexareports.com
Website: http://www.hexareports.com/
No comments:
Post a Comment